VBIO
Valion Bio
$0.62
−$0.06 (−9.13%)Oct 29, 2026
Key metrics
The numbers that frame VBIO today
- Market cap
- $547.64K
- Gross margin
- 66.7%
- ROIC
- -71.2%
- Div yield
- 0%
- Debt / equity
- 4.1
- 52wk Low
- $0.62
- 52wk High
- $67.50
Growth
Revenue and earnings trend for VBIO
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about VBIO
Is Valion Bio a good buy?
No. Valion Bio has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks strong, which supports the long-term business case, but that is not enough to offset the weak setup. We think Valion Bio is selling at a very high price.
What is the market capitalization of VBIO?
Valion Bio's market capitalization is $547.64K.
What is the 52-week high for VBIO stock?
The 52-week high for Valion Bio is $67.50. The current close of $0.62 is 99.1% below that high.
What is the 52-week low for VBIO stock?
The 52-week low for Valion Bio is $0.62. The current close of $0.62 is 0.2% above that low.
Does VBIO stock pay dividends?
Valion Bio does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for VBIO?
Valion Bio's Debt / Equity ratio is 4.1.